Peptidyl-urea based inhibitors of soluble epoxide hydrolases
- 15 October 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (20) , 5439-5444
- https://doi.org/10.1016/j.bmcl.2006.07.073
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological RolesAnnual Review of Pharmacology and Toxicology, 2005
- Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water SolubilityJournal of Medicinal Chemistry, 2005
- Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced HypertensionHypertension, 2005
- Epoxide hydrolases: their roles and interactions with lipid metabolismPublished by Elsevier ,2005
- Design, Synthesis, and Biological Activity of 1,3-Disubstituted Ureas as Potent Inhibitors of the Soluble Epoxide Hydrolase of Increased Water SolubilityJournal of Medicinal Chemistry, 2004
- Interactions with Aromatic Rings in Chemical and Biological RecognitionAngewandte Chemie International Edition in English, 2003
- Improved Intestinal Transport of PD 158473, an N-methyl-d-Aspartate (NMDA) Antagonist, by Involvement of Multiple TransportersJournal of Pharmaceutical Sciences, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Role of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular ToneJournal of Vascular Research, 1995